Indian population markers
Why allele frequencies differ, and why 30M builds PGx for Indian-population context.
Allele frequencies are not the same in every population. A panel copied from a Western catalogue can miss variants that are common here, and it can spend space on variants that are rare. That is a clinical problem, not a branding line.
30M Genomics builds pharmacogenomics for Indian-population context and uses FDA-approved markers. We do not claim every Indian ancestry is one number. We do claim that “import the US list” is not enough.
- Same drug, different variant mix across populations.
- Reports still need CPIC and a clinician.
- Markers stay inside an approved, medical-signed frame.
- Hyderabad is where we operate, not the limit of who we test.
Searches for “pharmacogenomics Hyderabad” or “genetic testing India” should be able to find a lab that states this. That is one reason these Learning pages exist: so the words on the homepage have a public, readable home.